Global Hemostats Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035
- PUBLISHED ON
- 10/11/2022
- NO OF PAGES
- 205
- CATEGORY
- Healthcare & Life Sciences
In 2021, the market for Hemostats worldwide was worth $2.9 billion US dollars. AMR Group projects that the market will reach US$ 4.8 billion by 2031, growing at a CAGR of 5.67 percent between 2022 and 2031.
Industry Overview
Hemostats are medical devices or substances that are used to stop bleeding by promoting coagulation (clotting) of blood. They are commonly used in surgical procedures to control bleeding, as well as in emergency situations to stop bleeding from wounds or injuries. Hemostats can be classified into two main categories: active hemostats and passive hemostats. Active hemostats are substances or devices that promote blood clotting by initiating the coagulation cascade, while passive hemostats are substances or devices that act as a mechanical barrier to stop bleeding. Examples of active hemostats include topical thrombin, fibrin sealants, and hemostatic agents such as oxidized regenerated cellulose and gelatin sponge. Examples of passive hemostats include collagen sponges, absorbable gelatin sponges, and synthetic hemostats such as polyethylene glycol. Hemostats are important tools in the medical field, as excessive bleeding can lead to serious complications and even death. However, their use must be carefully controlled to ensure that they do not cause adverse effects such as thrombosis or tissue damage. Hemostats should only be used by trained medical professionals in appropriate situations.
Market Dynamics
The global hemostats market is expected to grow in the coming years, driven by the increasing demand for surgical procedures, rising prevalence of chronic diseases, and growing aging population. One of the key drivers of the hemostats market is the growing number of surgical procedures being performed worldwide. With the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, there is a growing need for surgical intervention, which is driving the demand for hemostats. In addition, the aging population is also driving the growth of the hemostats market, as older individuals are more likely to require surgical intervention and are at a higher risk of bleeding complications.
The increasing number of traumatic injuries is also driving demand for hemostats in emergency medical settings. However, the high cost of hemostats and the availability of alternative products such as sealants and adhesives may hinder the growth of the market to some extent. In addition, the lack of reimbursement for some hemostats in certain regions may also limit market growth. The hemostats market is highly competitive, with a number of players operating in the space. Key players in the market include Johnson & Johnson, Baxter International Inc., C.R. Bard Inc., B. Braun Melsungen AG, and Pfizer Inc. These companies are investing in research and development to develop new and innovative hemostats, as well as engaging in mergers and acquisitions to expand their market share.
COVID Impact
The COVID-19 pandemic has had a mixed impact on the hemostats market. On one hand, the pandemic has led to a surge in demand for hemostats in emergency medical settings, particularly in the treatment of severe COVID-19 patients who may experience coagulation disorders and bleeding complications. On the other hand, the pandemic has led to disruptions in the supply chain, which has affected the production and distribution of hemostats. The lockdowns and travel restrictions imposed by governments around the world have led to delays in the shipment of raw materials and finished products, leading to supply shortages in some regions. In addition, the COVID-19 pandemic has led to a shift in priorities in the healthcare industry, with a greater focus on the treatment and prevention of the virus. This has led to a reduction in the number of elective surgeries being performed, which has affected the demand for hemostats. Overall, the impact of COVID-19 on the hemostats market has been mixed, with increased demand in emergency medical settings offset by supply chain disruptions and a reduction in elective surgeries. However, the market is expected to recover in the coming years, as the pandemic subsides and healthcare systems return to normal operations.
Regional Trend
The hemostats market can be analyzed based on regional segments such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest market for hemostats, driven by the high prevalence of chronic diseases and the growing aging population. The region has a well-established healthcare infrastructure and a high level of healthcare expenditure, which supports the adoption of new medical technologies. Key players in the market are also based in North America, which contributes to the market's growth. Europe is another significant market for hemostats, driven by the increasing demand for surgical procedures and the presence of a large number of medical device manufacturers. The region has a well-established regulatory framework that ensures the safety and efficacy of medical devices, which supports the adoption of new hemostats.
The Asia Pacific hemostats market is expected to grow at a significant rate, driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and the growing demand for surgical procedures in the region. The region is home to a large population and has a rapidly growing aging population, which is driving the demand for medical technologies such as hemostats. Latin America and the Middle East & Africa hemostats market are also expected to grow in the coming years, driven by increasing investments in healthcare infrastructure and the growing demand for medical technologies in the region.
Competitive Landscape
The global hemostats market is highly competitive, with a large number of players operating in the space. The market is characterized by the presence of both global and regional players, with the global players dominating the market share. Some of the key players in the hemostats market include Johnson & Johnson, Baxter International Inc., C.R. Bard Inc., B. Braun Melsungen AG, Pfizer Inc., Medtronic plc, Integra LifeSciences Corporation, Ethicon Inc., Zimmer Biomet Holdings, Inc., and CryoLife, Inc. These companies are investing in research and development to develop new and innovative hemostats, as well as engaging in mergers and acquisitions to expand their market share. For example, in 2020, Johnson & Johnson acquired the assets of the surgical division of the LifeScan business of Animas Corporation, which included hemostatic products such as SURGICEL and SURGIFLO. In 2019, Baxter International Inc. acquired Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million to expand its surgical portfolio. In addition, several new players are entering the market, with a focus on developing innovative products that address the unmet needs of patients and healthcare providers. For example, in 2019, Arch Therapeutics, Inc. received clearance from the U.S. FDA for its AC5 Advanced Wound System, a self-assembling peptide product that can be used as a hemostat.
Market Segmentation
The hemostats market can be segmented based on the product type, application, end-user, and region.
Based on the product type, the hemostats market can be segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, collagen-based hemostats, and others.
Based on the application, the market can be segmented into general surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, urological surgery, reconstructive surgery, and others.
Based on the end-user, the market can be segmented into hospitals, ambulatory surgical centers, and specialty clinics.
Based on the region, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The thrombin-based hemostats segment is expected to hold the largest share of the hemostats market, driven by its effectiveness in controlling bleeding and its ability to work quickly. The cardiovascular surgery segment is expected to hold the largest share of the market by application, driven by the high prevalence of cardiovascular diseases and the increasing demand for cardiovascular surgeries. Hospitals are expected to be the largest end-user segment of the market, driven by the high patient volume and the availability of advanced medical technologies in hospitals.
Global Hemostats Market: Market Size EstimationBoth the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of various marketspaces. The key players in the markets are identified through secondary research, and their market contributions in different applications across regions and globally were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis from Analytics Market Research added before being presented in this report.
Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?
Historic Year: 2016-2022
Forecast: 2024-2035
1 Hemostats Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Hemostats
1.3 Hemostats Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Hemostats Revenue and Growth Rate from 2016-2030
1.4 Market Segmentation
1.4.1 Types of Hemostats
1.4.2 Applications of Hemostats
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Hemostats Industry Trends
1.5.2 Hemostats Drivers
1.5.3 Hemostats Market Challenges
1.5.4 Hemostats Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Hemostats Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Hemostats Industry Development
2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Hemostats Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Hemostats
2.2.1 Major Players Manufacturing Base of Hemostats in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Hemostats Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Hemostats
2.3.3 Labor Cost of Hemostats
2.4 Market Channel Analysis of Hemostats
2.5 Major Down Stream Customers by Application
3 Global Hemostats Market, by Type
3.1 Global Hemostats Revenue and Market Share by Type (2016-2021)
3.2 Global Hemostats Production and Market Share by Type (2016-2021)
3.3 Global Hemostats Revenue and Growth Rate by Type (2016-2021)
3.3.1 Global Hemostats Revenue and Growth Rate of Thrombin
3.3.2 Global Hemostats Revenue and Growth Rate of Oxidised Regenerated Cellulose
3.3.3 Global Hemostats Revenue and Growth Rate of Combination
3.3.4 Global Hemostats Revenue and Growth Rate of Gelatin
3.3.5 Global Hemostats Revenue and Growth Rate of Collagen
3.4 Global Hemostats Price Analysis by Type (2016-2021)
3.4.1 Explanation of Different Type Product Price Trends
4 Hemostats Market, by Application
4.1 Downstream Market Overview
4.2 Global Hemostats Consumption and Market Share by Application (2016-2021)
4.3 Global Hemostats Consumption and Growth Rate by Application (2016-2021)
4.3.1 Global Hemostats Consumption and Growth Rate of Gynecology (2016-2021)
4.3.2 Global Hemostats Consumption and Growth Rate of Neurology (2016-2021)
4.3.3 Global Hemostats Consumption and Growth Rate of Cardiovascular (2016-2021)
4.3.4 Global Hemostats Consumption and Growth Rate of Reconstructive (2016-2021)
5 Global Hemostats Consumption, Revenue ($) by Region (2016-2021)
5.1 Global Hemostats Revenue and Market Share by Region (2016-2021)
5.2 Global Hemostats Consumption and Market Share by Region (2016-2021)
5.3 Global Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.4 North America Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.4.1 North America Hemostats Market Under COVID-19
5.4.2 North America Hemostats SWOT Analysis
5.5 Europe Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.5.1 Europe Hemostats Market Under COVID-19
5.5.2 Europe Hemostats SWOT Analysis
5.6 China Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.6.1 China Hemostats Market Under COVID-19
5.6.2 China Hemostats SWOT Analysis
5.7 Japan Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.7.1 Japan Hemostats Market Under COVID-19
5.7.2 Japan Hemostats SWOT Analysis
5.8 Middle East and Africa Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.8.1 Middle East and Africa Hemostats Market Under COVID-19
5.8.2 Middle East and Africa Hemostats SWOT Analysis
5.9 India Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.9.1 India Hemostats Market Under COVID-19
5.9.2 India Hemostats SWOT Analysis
5.10 South America Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.10.1 South America Hemostats Market Under COVID-19
5.10.2 South America Hemostats SWOT Analysis
5.11 South Korea Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.11.1 South Korea Hemostats Market Under COVID-19
5.11.2 South Korea Hemostats SWOT Analysis
5.12 Southeast Asia Hemostats Consumption, Revenue, Price and Gross Margin (2016-2021)
5.12.1 Southeast Asia Hemostats Market Under COVID-19
5.12.2 Southeast Asia Hemostats SWOT Analysis
6 Global Hemostats Production by Top Regions (2016-2021)
6.1 Global Hemostats Production by Top Regions (2016-2021)
6.2 North America Hemostats Production and Growth Rate
6.3 Europe Hemostats Production and Growth Rate
6.4 China Hemostats Production and Growth Rate
6.5 Japan Hemostats Production and Growth Rate
6.6 India Hemostats Production and Growth Rate
7 Global Hemostats Consumption by Regions (2016-2021)
7.1 Global Hemostats Consumption by Regions (2016-2021)
7.2 North America Hemostats Consumption and Growth Rate
7.3 Europe Hemostats Consumption and Growth Rate
7.4 China Hemostats Consumption and Growth Rate
7.5 Japan Hemostats Consumption and Growth Rate
7.6 Middle East & Africa Hemostats Consumption and Growth Rate
7.7 India Hemostats Consumption and Growth Rate
7.8 South America Hemostats Consumption and Growth Rate
7.9 South Korea Hemostats Consumption and Growth Rate
7.10 Southeast Asia Hemostats Consumption and Growth Rate
8 Competitive Landscape
8.1 Competitive Profile
8.2 C. R. Bard Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Hemostats Product Profiles, Application and Specification
8.2.3 C. R. Bard Sales, Revenue, Price, Gross Margin 2016-2021
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Gelita Medical GmbH Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Hemostats Product Profiles, Application and Specification
8.3.3 Gelita Medical GmbH Sales, Revenue, Price, Gross Margin 2016-2021
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Ethicon, Inc. Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Hemostats Product Profiles, Application and Specification
8.4.3 Ethicon, Inc. Sales, Revenue, Price, Gross Margin 2016-2021
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 BioCer Entwicklungs-GmbH Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Hemostats Product Profiles, Application and Specification
8.5.3 BioCer Entwicklungs-GmbH Sales, Revenue, Price, Gross Margin 2016-2021
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Integra LifeSciences Corporation Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Hemostats Product Profiles, Application and Specification
8.6.3 Integra LifeSciences Corporation Sales, Revenue, Price, Gross Margin 2016-2021
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Biom'Up SAS Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Hemostats Product Profiles, Application and Specification
8.7.3 Biom'Up SAS Sales, Revenue, Price, Gross Margin 2016-2021
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 B Braun Melsungen AG Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Hemostats Product Profiles, Application and Specification
8.8.3 B Braun Melsungen AG Sales, Revenue, Price, Gross Margin 2016-2021
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 CryoLife, Inc. Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Hemostats Product Profiles, Application and Specification
8.9.3 CryoLife, Inc. Sales, Revenue, Price, Gross Margin 2016-2021
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 The Medicines Company Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Hemostats Product Profiles, Application and Specification
8.10.3 The Medicines Company Sales, Revenue, Price, Gross Margin 2016-2021
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Vascular Solutions, Inc Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Hemostats Product Profiles, Application and Specification
8.11.3 Vascular Solutions, Inc Sales, Revenue, Price, Gross Margin 2016-2021
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Equimedical Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Hemostats Product Profiles, Application and Specification
8.12.3 Equimedical Sales, Revenue, Price, Gross Margin 2016-2021
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Marine Polymer Technologies, Inc. Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Hemostats Product Profiles, Application and Specification
8.13.3 Marine Polymer Technologies, Inc. Sales, Revenue, Price, Gross Margin 2016-2021
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Baxter International Inc. Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Hemostats Product Profiles, Application and Specification
8.14.3 Baxter International Inc. Sales, Revenue, Price, Gross Margin 2016-2021
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Z-Medica, LLC Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Hemostats Product Profiles, Application and Specification
8.15.3 Z-Medica, LLC Sales, Revenue, Price, Gross Margin 2016-2021
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 Pfizer, Inc. Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Hemostats Product Profiles, Application and Specification
8.16.3 Pfizer, Inc. Sales, Revenue, Price, Gross Margin 2016-2021
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Anika Therapeutics, Inc Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Hemostats Product Profiles, Application and Specification
8.17.3 Anika Therapeutics, Inc Sales, Revenue, Price, Gross Margin 2016-2021
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Advanced Medical Solutions Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Hemostats Product Profiles, Application and Specification
8.18.3 Advanced Medical Solutions Sales, Revenue, Price, Gross Margin 2016-2021
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
9 Global Hemostats Market Analysis and Forecast by Type and Application
9.1 Global Hemostats Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Thrombin Market Revenue and Volume Forecast (2021-2026)
9.1.2 Oxidised Regenerated Cellulose Market Revenue and Volume Forecast (2021-2026)
9.1.3 Combination Market Revenue and Volume Forecast (2021-2026)
9.1.4 Gelatin Market Revenue and Volume Forecast (2021-2026)
9.1.5 Collagen Market Revenue and Volume Forecast (2021-2026)
9.2 Global Hemostats Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Gynecology Market Revenue and Volume Forecast (2021-2026)
9.2.2 Neurology Market Revenue and Volume Forecast (2021-2026)
9.2.3 Cardiovascular Market Revenue and Volume Forecast (2021-2026)
9.2.4 Reconstructive Market Revenue and Volume Forecast (2021-2026)
10 Hemostats Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Hemostats Market Trends Analysis
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
 
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.
}})
Select a license type that suits your business needs
US $3950
Only Three Thousand Nine Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4950
Only Four Thousand Nine Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5950
Only Five Thousand Nine Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI